Crossmark

Extracorporeal adsorption of protective and toxic bile acids and bilirubin in patients with cholestatic liver dysfunction: a prospective study

Crossref DOI link: https://doi.org/10.1186/s13613-023-01198-7

Published Print: 2023

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Greimel, Antonia

Habler, Katharina

Gräfe, Caroline

Maciuga, Nils

Brozat, Clara Isabell

Vogeser, Michael

Zoller, Michael

Happich, Felix L.

Liebchen, Uwe

Frank, Sandra

Paal, Michael

Scharf, Christina
Clinical Trials ^BETA

Clinical trials referenced in this document:

nct04913298 at ClinicalTrials.gov

Documents that mention this clinical trial

Extracorporeal adsorption of protective and toxic bile acids and bilirubin in patients with cholestatic liver dysfunction: a prospective study
https://doi.org/10.1186/s13613-023-01198-7

Extracorporeal Elimination of Pro- and Anti-inflammatory Modulators by the Cytokine Adsorber CytoSorb® in Patients with Hyperinflammation: A Prospective Study
https://doi.org/10.1007/s40121-024-01028-8
Funding

Funding for this research was provided by:

Else Kröner-Fresenius-Stiftung (2021_EKEA.101)

Universitätsklinik München
License Information

Text and Data Mining valid from 2023-01-01

Text and Data Mining valid from 2023-01-01

Version of Record valid from 2025-11-19
More Information

This article is maintained by: Elsevier

Article Title: Extracorporeal adsorption of protective and toxic bile acids and bilirubin in patients with cholestatic liver dysfunction: a prospective study

Journal Title: Annals of Intensive Care

CrossRef DOI link to publisher maintained version: https://doi.org/10.1186/s13613-023-01198-7

Content Type: article

Copyright: Copyright © 2023 The Author(s) 2023. Published by Elsevier Masson SAS